Doxycycline inhibits TREM-1 induction by Porphyromonas gingivalis

FEMS Immunology and Medical Microbiology

Volumn 66, Issue 1, 2012, Pages 37-44

  Bostanci, Nagihan ^a   Belibasakis, Georgios N ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Doxycycline; Inflammation; Monocytes; Periodontal disease; Porphyromonas gingivalis; TREM 1

Indexed keywords

CELL SURFACE RECEPTOR; DOXYCYCLINE; IMMUNOGLOBULIN; INTERLEUKIN 8; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; MONOCYTE; NONHUMAN; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; PROTEIN SECRETION;

ANTI-BACTERIAL AGENTS; CELL LINE; DOXYCYCLINE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-8; MEMBRANE GLYCOPROTEINS; MONOCYTES; PORPHYROMONAS GINGIVALIS; RECEPTORS, IMMUNOLOGIC; TIME FACTORS;

EID: 84866183515     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2012.00982.x     Document Type: Article

References (63)

1. Aoki N, Zganiacz A, Margetts P & Xing Z (2004) Differential regulation of DAP12 and molecules associated with DAP12 during host responses to mycobacterial infection. Infect Immun 72: 2477-2483.
2. Begum NA, Ishii K, Kurita-Taniguchi M et al. (2004) Mycobacterium bovis BCG cell wall-specific differentially expressed genes identified by differential display and cDNA subtraction in human macrophages. Infect Immun 72: 937-948.
3. Bleharski JR, Kiessler V, Buonsanti C, Sieling PA, Stenger S, Colonna M & Modlin RL (2003) A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol 170: 3812-3818.
4. Bostanci N, Allaker RP, Belibasakis GN, Rangarajan M, Curtis MA, Hughes FJ & McKay IJ (2007a) Porphyromonas gingivalis antagonises Campylobacter rectus induced cytokine production by human monocytes. Cytokine 39: 147-156.
5. Bostanci N, Allaker R, Johansson U, Rangarajan M, Curtis MA, Hughes FJ & McKay IJ (2007b) Interleukin-1alpha stimulation in monocytes by periodontal bacteria: antagonistic effects of Porphyromonas gingivalis. Oral Microbiol Immunol 22: 52-60.
6. Bostanci N, Reddi D, Rangarajan M, Curtis MA & Belibasakis GN (2009) Porphyromonas gingivalis stimulates TACE production by T cells. Oral Microbiol Immunol 24: 146-151.
7. Bostanci N, Thurnheer T & Belibasakis GN (2011a) Involvement of the TREM-1/DAP12 pathway in the innate immune responses to Porphyromonas gingivalis. Mol Immunol 49: 387-394.
8. Bostanci N, Akgul B, Tsakanika V, Allaker RP, Hughes FJ & McKay IJ (2011b) Effects of low-dose doxycycline on cytokine secretion in human monocytes stimulated with Aggregatibacter actinomycetemcomitans. Cytokine 56: 656-661.
9. Bouchon A, Dietrich J & Colonna M (2000) Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164: 4991-4995.
10. Bouchon A, Facchetti F, Weigand MA & Colonna M (2001) TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 410: 1103-1107.
11. Brodala N, Merricks EP, Bellinger DA et al. (2005) Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol 25: 1446-1451.
12. Buckland KF, Ramaprakash H, Murray LA et al. (2011) Triggering Receptor Expressed on Myeloid cells-1 (TREM-1) Modulates Immune Responses to Aspergillus fumigatus During Fungal Asthma in Mice. Immunol Invest 40: 692-722.
13. Caton J & Ryan ME (2011) Clinical studies on the management of periodontal diseases utilizing subantimicrobial dose doxycycline (SDD). Pharmacol Res 63: 114-120.
14. Cavaillon JM (2009) Monocyte TREM-1 membrane expression in non-infectious inflammation. Crit Care 13: 152.
15. Cazalis J, Bodet C, Gagnon G & Grenier D (2008) Doxycycline reduces lipopolysaccharide-induced inflammatory mediator secretion in macrophage and ex vivo human whole blood models. J Periodontol 79: 1762-1768.
16. Collins CE, La DT, Yang HT, Massin F, Gibot S, Faure G & Stohl W (2009) Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis. Ann Rheum Dis 68: 1768-1774.
17. Colonna M & Facchetti F (2003) TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J Infect Dis 187(Suppl 2): S397-S401.
18. Colonna M, Turnbull I & Klesney-Tait J (2007) The enigmatic function of TREM-2 in osteoclastogenesis. Adv Exp Med Biol 602: 97-105.
19. Darveau RP (2011) Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol 8: 481-490.
20. del Fresno C, Gomez-Pina V, Lores V et al. (2008) Monocytes from cystic fibrosis patients are locked in an LPS tolerance state: down-regulation of TREM-1 as putative underlying mechanism. PLoS ONE 3: e2667.
21. Emingil G, Gurkan A, Atilla G & Kantarci A (2011) Subantimicrobial-dose doxycycline and cytokine-chemokine levels in gingival crevicular fluid. J Periodontol 82: 452-461.
22. Ferat-Osorio E, Wong-Baeza I, Esquivel-Callejas N et al. (2009) Triggering receptor expressed on myeloid cells-1 expression on monocytes is associated with inflammation but not with infection in acute pancreatitis. Crit Care 13: R69.
23. Gibot S & Cravoisy A (2004) Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection. Clin Med Res 2: 181-187.
24. Gibot S, Cravoisy A, Levy B, Bene MC, Faure G & Bollaert PE (2004a) Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 350: 451-458.
25. Gibot S, Kolopp-Sarda MN, Bene MC, Cravoisy A, Levy B, Faure GC & Bollaert PE (2004b) Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 141: 9-15.
26. Gibot S, Kolopp-Sarda MN, Bene MC, Bollaert PE, Lozniewski A, Mory F, Levy B & Faure GC (2004c) A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med 200: 1419-1426.
27. Gibot S, Cravoisy A, Kolopp-Sarda MN, Bene MC, Faure G, Bollaert PE & Levy B (2005) Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med 33: 792-796.
28. Golub LM, McNamara TF, Ryan ME, Kohut B, Blieden T, Payonk G, Sipos T & Baron HJ (2001) Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 28: 146-156.
29. Gomez-Pina V, Soares-Schanoski A, Rodriguez-Rojas A, Del Fresno C, Garcia F, Vallejo-Cremades MT, Fernandez-Ruiz I, Arnalich F, Fuentes-Prior P & Lopez-Collazo E (2007) Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J Immunol 179: 4065-4073.
30. Gu Y, Lee HM, Sorsa T, Salminen A, Ryan ME, Slepian MJ & Golub LM (2011) Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: a mechanistic link between local and systemic inflammation. Pharmacol Res 64: 573-579.
31. Gurkan A, Emingil G, Cinarcik S & Berdeli A (2008) Post-treatment effects of subantimicrobial dose doxycycline on clinical parameters and gingival crevicular fluid transforming growth factor-beta1 in severe, generalized chronic periodontitis. Int J Dent Hyg 6: 84-92.
32. Hajishengallis G (2009) Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics? Microbes Infect 11: 637-645.
33. Hajishengallis G, Wang M, Liang S, Shakhatreh MA, James D, Nishiyama S, Yoshimura F & Demuth DR (2008) Subversion of innate immunity by periodontopathic bacteria via exploitation of complement receptor-3. Adv Exp Med Biol 632: 203-219.
34. Hajishengallis G, Liang S, Payne MA et al. (2011) Low-Abundance Biofilm Species Orchestrates Inflammatory Periodontal Disease through the Commensal Microbiota and Complement. Cell Host Microbe 10: 497-506.
35. Hamedi M, Belibasakis GN, Cruchley AT, Rangarajan M, Curtis MA & Bostanci N (2009) Porphyromonas gingivalis culture supernatants differentially regulate interleukin-1beta and interleukin-18 in human monocytic cells. Cytokine 45: 99-104.
36. How CK, Hou SK, Shih HC, Yen DH, Huang CI, Lee CH & Tang GJ (2011) Usefulness of triggering receptor expressed on myeloid cells-1 in differentiating between typical and atypical community-acquired pneumonia. Am J Emerg Med 29: 626-631.
37. Kaifu T, Nakahara J, Inui M et al. (2003) Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J Clin Invest 111: 323-332.
38. Klesney-Tait J, Turnbull IR & Colonna M (2006) The TREM receptor family and signal integration. Nat Immunol 7: 1266-1273.
39. Knapp S, Gibot S, de Vos A, Versteeg HH, Colonna M & van der Poll T (2004) Cutting edge: expression patterns of surface and soluble triggering receptor expressed on myeloid cells-1 in human endotoxemia. J Immunol 173: 7131-7134.
40. Krakauer T & Buckley M (2003) Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced cytokines and chemokines. Antimicrob Agents Chemother 47: 3630-3633.
41. Kusanovic JP, Romero R, Chaiworapongsa T et al. (2011) Amniotic fluid sTREM-1 in normal pregnancy, spontaneous parturition at term and preterm, and intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med 23: 34-47.
42. Liang S, Domon H, Hosur KB, Wang M & Hajishengallis G (2009) Age-related alterations in innate immune receptor expression and ability of macrophages to respond to pathogen challenge in vitro. Mech Ageing Dev 130: 538-546.
43. Liao F, Li Z, Wang Y, Shi B, Gong Z & Cheng X (2009) Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis. Med Hypotheses 72: 732-735.
44. Lin D, Smith MA, Champagne C, Elter J, Beck J & Offenbacher S (2003) Porphyromonas gingivalis infection during pregnancy increases maternal tumor necrosis factor alpha, suppresses maternal interleukin-10, and enhances fetal growth restriction and resorption in mice. Infect Immun 71: 5156-5162.
45. Maekawa T, Takahashi N, Honda T, Yonezawa D, Miyashita H, Okui T, Tabeta K & Yamazaki K (2011a) Porphyromonas gingivalis antigens and interleukin-6 stimulate the production of monocyte chemoattractant protein-1 via the upregulation of early growth response-1 transcription in human coronary artery endothelial cells. J Vasc Res 47: 346-354.
46. Maekawa T, Takahashi N, Tabeta K, Aoki Y, Miyashita H, Miyauchi S, Miyazawa H, Nakajima T & Yamazaki K (2011b) Chronic Oral Infection with Porphyromonas gingivalis Accelerates Atheroma Formation by Shifting the Lipid Profile. PLoS ONE 6: e20240.
47. McInnes IB & Schett G (2007) Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7: 429-442.
48. Paloneva J, Kestila M, Wu J et al. (2000) Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat Genet 25: 357-361.
49. Paloneva J, Mandelin J, Kiialainen A, Bohling T, Prudlo J, Hakola P, Haltia M, Konttinen YT & Peltonen L (2003) DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features. J Exp Med 198: 669-675.
50. Preshaw PM, Hefti AF & Bradshaw MH (2005) Adjunctive subantimicrobial dose doxycycline in smokers and non-smokers with chronic periodontitis. J Clin Periodontol 32: 610-616.
51. Ramanathan B, Minton JE, Ross CR & Blecha F (2005) Cloning of porcine triggering receptor expressed on myeloid cells-1 (TREM-1) and its induction by lipopolysaccharide, peptidoglycan, and Salmonella enterica serovar Typhimurium infection. Dev Comp Immunol 29: 1-7.
52. Richeldi L, Mariani M, Losi M, Maselli F, Corbetta L, Buonsanti C, Colonna M, Sinigaglia F, Panina-Bordignon P & Fabbri LM (2004) Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J 24: 247-250.
53. Salvi GE, Yalda B, Collins JG, Jones BH, Smith FW, Arnold RR & Offenbacher S (1997) Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol 68: 127-135.
54. Schmausser B, Endrich S, Beier D, Moran AP, Burek CJ, Rosenwald A, Rieckmann P, Muller-Hermelink HK & Eck M (2008) Triggering receptor expressed on myeloid cells-1 (TREM-1) expression on gastric epithelium: implication for a role of TREM-1 in Helicobacter pylori infection. Clin Exp Immunol 152: 88-94.
55. Shapira L, Soskolne WA, Houri Y, Barak V, Halabi A & Stabholz A (1996) Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect Immun 64: 825-828.
56. Shapira L, Barak V, Soskolne WA, Halabi A & Stabholz A (1998) Effects of tetracyclines on the pathologic activity of endotoxin: in vitro and in vivo studies. Adv Dent Res 12: 119-122.
57. Thomas J, Walker C & Bradshaw M (2000) Long-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibility. J Periodontol 71: 1472-1483.
58. Tong J, Liu ZC & Wang DX (2011) Azithromycin acts as an immunomodulatory agent to suppress the expression of TREM-1 in Bacillus pyocyaneus-induced sepsis. Immunol Lett 138: 137-143.
59. Turnbull IR & Colonna M (2007) Activating and inhibitory functions of DAP12. Nat Rev Immunol 7: 155-161.
60. Uitto VJ, Firth JD, Nip L & Golub LM (1994) Doxycycline and chemically modified tetracyclines inhibit gelatinase A (MMP-2) gene expression in human skin keratinocytes. Ann NY Acad Sci 732: 140-151.
61. Walker C, Preshaw PM, Novak J, Hefti AF, Bradshaw M & Powala C (2005) Long-term treatment with sub-antimicrobial dose doxycycline has no antibacterial effect on intestinal flora. J Clin Periodontol 32: 1163-1169.
62. Wong-Baeza I, Gonzalez-Roldan N, Ferat-Osorio E et al. (2006) Triggering receptor expressed on myeloid cells (TREM-1) is regulated post-transcriptionally and its ligand is present in the sera of some septic patients. Clin Exp Immunol 145: 448-455.
63. Zeng H, Ornatowska M, Joo MS & Sadikot RT (2007) TREM-1 expression in macrophages is regulated at transcriptional level by NF-kappaB and PU.1. Eur J Immunol 37: 2300-2308.